Resmed Inc
(RMD)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 06/30
(Values in U.S. thousands)
| 06-2025 | 06-2024 | 06-2023 | 06-2022 | 06-2021 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 1,400,723 | 1,020,951 | 897,556 | 779,437 | 474,505 |
| Depreciation Amortization | 235,811 | 216,209 | 197,562 | 193,841 | 191,518 |
| Accounts receivable | -76,684 | -134,278 | -106,511 | 19,346 | -129,195 |
| Other Working Capital | 16,738 | 44,784 | -462,127 | -708,076 | 1,405 |
| Other Operating Activity | 175,000 | 253,594 | 166,819 | 66,599 | 198,485 |
| Operating Cash Flow | $1,751,588 | $1,401,260 | $693,299 | $351,147 | $736,718 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -1,788 | -11,765 | -28,292 | -13,922 | -21,788 |
| PPE Investments | -89,865 | -99,460 | -119,672 | -134,835 | -102,712 |
| Net Acquisitions | -139,248 | -133,464 | -1,012,749 | -42,784 | -39,067 |
| Purchase Sale Intangibles | -10,777 | -15,396 | -14,328 | -21,201 | -14,114 |
| Other Investing Activity | 30,856 | -25,095 | 868 | -38,377 | 5,105 |
| Investing Cash Flow | $-200,045 | $-269,784 | $-1,159,845 | $-229,918 | $-158,462 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 0 | 105,000 | 1,070,000 | 288,000 | 90,000 |
| Debt Repayment | -40,000 | -835,000 | -405,000 | -166,000 | -612,000 |
| Common Stock Issued | 74,439 | 53,094 | 49,142 | 47,384 | 37,790 |
| Common Stock Repurchased | -300,025 | -150,011 | 0 | N/A | N/A |
| Dividend Paid | -310,880 | -282,320 | -258,276 | -245,341 | -226,713 |
| Other Financing Activity | -29,787 | -10,050 | -32,992 | -52,406 | -53,709 |
| Financing Cash Flow | $-606,253 | $-1,119,287 | $422,874 | $-128,363 | $-764,632 |
| Exchange Rate Effect | 25,799 | -1,719 | -2,147 | -14,434 | 18,498 |
| Beginning Cash Position | 238,361 | 227,891 | 273,710 | 295,278 | 463,156 |
| End Cash Position | 1,209,450 | 238,361 | 227,891 | 273,710 | 295,278 |
| Net Cash Flow | $971,089 | $10,470 | $-45,819 | $-21,568 | $-167,878 |
| Free Cash Flow | |||||
| Operating Cash Flow | 1,751,588 | 1,401,260 | 693,299 | 351,147 | 736,718 |
| Capital Expenditure | -89,865 | -99,460 | -119,672 | -134,835 | -102,712 |
| Free Cash Flow | 1,661,723 | 1,301,800 | 573,627 | 216,312 | 634,006 |